VEA
DGX icon

Virtus ETF Advisers’s Quest Diagnostics DGX Stock Holding History

Virtus ETF Advisers’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,037
Closed -$854K – 450
2023
Q1 		$854K Buy
6,037
+389
+7% +$55.7K 0.47% 75
2022
Q4 		$884K Buy
5,648
+601
+12% +$86.4K 0.46% 28
2022
Q3 		$619K Sell
5,047
-269
-5% -$35.4K 0.25% 161
2022
Q2 		$707K Buy
+5,316
New +$724K 0.26% 117

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Virtus ETF Advisers's DGX Position: Q2 2023 in Review

Virtus ETF Advisers sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 6,037 shares — an estimated $854K sold.

Virtus ETF Advisers first reported a position in DGX in Q2 2022 and held it in 4 quarters. The position peaked at $884K in Q4 2022. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • Virtus ETF Advisers reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 6,037 Quest Diagnostics shares in Q2 2023, an estimated $854K.
  • Virtus ETF Advisers first reported a position in Quest Diagnostics in Q2 2022 and held it in 4 quarters.
  • Virtus ETF Advisers's Quest Diagnostics position peaked at $884K in Q4 2022.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Virtus ETF Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.